📌 Key Takeaways
- Topic: Colloidal Silicon Dioxide Excipient: Uses as a Glidant and Pharmacopeia Standards
- Keywords: silica SDS
- Published: 2026-11-20 09:37:15
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Acidic Silica Sol: Properties, Stability and Applications
- Silicon Dioxide Manufacturer: Production Methods, Quality Standards and Selection Tips
- Mesoporous carriers also offer an attractive alternative in the oral therapy of macromolecules rather than the more complicated parenteral administration. Peptides and proteins may denature in the greatly acidic environment of the stomach, lose their structure and function [ 1, 13 ], while the proteases in the digestive system break down the protein chains, making the molecule useless and the therapy ineffective [ 1, 13, 91 ]. Additionally, poor permeation through the epithelium is another hindering component during the oral administration of macromolecules [ 1, 13 ]. The macromolecule locked inside the pores stays protected against enzymatic or chemical degradation, and its permeation through the epithelium can also be improved [ 1, 13, 91 ]. It is also true that smaller pores deliver better protection for macromolecules against degradation [ 1 ]. Mesoporous silica nanocarriers have extra intriguing advantages because of their special properties that make them outstanding over other carriers and therefore provide a popular alternative in formulating macromolecules [ 1, 13 ].
- Silica Reinforcing Filler: How It Strengthens Rubber and Polymers
- Silica Bulk Density: Typical Values by Type and Why It Matters for Handling
- 2.1. Particle Size
- What Is Silane Treated Silica? How Silane Modification Improves Dispersion and Performance
- 25. Janjua T.I., Cao Y., Kleitz F., Linden M., Yu C., Popat A. Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers. Adv. Drug Deliv. Rev. 2023;203:115115. doi: 10.1016/j.addr.2023.115115. [ DOI ] [ PubMed ] [ Google Scholar ]
Semiconductor Grade Silica: Purity Standards, Key Specs and Typical Uses
What is silica (SiO₂)?
quartz crucible sand Mesoporous silica nanoparticles (MSNs) are a flexible platform for the improvement of water solubility and bioavailability of poorly water-soluble drugs through the stabilization of the API in the amorphous state. Two outstanding mechanisms facilitate such stabilization: physical entrapment within nanoscale pores with a diameter less than the size of the critical nucleus. In this case, the ordered molecular packing necessary to develop crystals cannot advance. Moreover, the unique interactions between the functional groups of APIs and the surface silanol groups of MSNs may immobilize drug molecules at or close to pore walls [ 44, 45 ]. Bavnhøj et al. used celecoxib to demonstrate that when loading is conducted under the pore-filling ability (PFC) of the silica matrix, the drug will be physically stable and amorphous for at least 18 months of dry storage. PFC-loaded along with near-PFC-loaded samples recrystallized, especially upon exposure to moisture, demonstrating the razor-thin margin between the level of loading and stability [ 46 ]. Although advantages are present, long-term stability is undermined by stress recrystallization. For example, α-mangostin began to recrystallize after 7-14 days at 25 °C and 95% relative humidity in MSNs with slightly broader pore size than the molecular size of the API, indicating that pore size must be finely tuned for productive confinement [ 47 ]. Similarly, simvastatin had the longest amorphous lifespan when loaded into pores of 4.5 nm. Still, it exhibited rapid recrystallization in materials with bigger pore size, underlining the critical importance of pore size for the preservation of amorphous stability [ 45, 47 ].
What is the difference between fumed silica and precipitated silica?
What drives silica raw material prices?
silica thermal insulation 52. Minecka A., Tarnacka M., Jurkiewicz K., Żakowiecki D., Kamiński K., Kamińska E. Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole. Mol. Pharm. 2023;20:5655-5667. doi: 10.1021/acs.molpharmaceut.3c00524. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.